Total submissions: 4
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV000219732 | SCV000275695 | likely benign | Hereditary cancer-predisposing syndrome | 2015-05-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
| Labcorp Genetics |
RCV003765418 | SCV000562601 | likely benign | Familial adenomatous polyposis 1 | 2024-09-21 | criteria provided, single submitter | clinical testing | |
| All of Us Research Program, |
RCV003997924 | SCV004837449 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-10-06 | criteria provided, single submitter | clinical testing | |
| Myriad Genetics, |
RCV003765418 | SCV004932758 | benign | Familial adenomatous polyposis 1 | 2024-03-26 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |